GlassScriptPhysician profile
Christine Min
NPI 1609039882
$1,353.04
in general payments reported to CMS, 2019-2025
19 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $104 · 2021: $218 · 2022: $213 · 2023: $72.54 · 2024: $50.00 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $199.76 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $188.00 | 2022 | |
| Siemens Medical Solutions USA, INC. | $180.06 | 2021-2023 | Magnetom Vida |
| Reflexion Medical, INC. | $175.00 | 2022-2025 | Reflexion Medical Radiotherapy System |
| E.R. Squibb & Sons, L.L.C. | $119.94 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $94.08 | 2019-2025 | |
| Seagen INC. | $82.93 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $47.00 | 2019 | |
| Tesaro, INC. | $41.27 | 2019 | |
| Fortovia Therapeutics, INC. | $40.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.03 | 2019-2020 | |
| Novocure INC. | $29.13 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.24 | 2025 | |
| Angiodynamics, INC. | $21.66 | 2019 | |
| Clovis Oncology, INC. | $21.63 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.05 | 2019 | |
| Eisai INC. | $14.39 | 2019 | |
| Pfizer INC. | $11.92 | 2020 | |
| Abbvie INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.